These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18264945)

  • 21. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H; Hiki Y; Takahashi M; Nishimoto A; Yasuda Y; Iwase H; Shinzato T; Maeda K
    Biochem Biophys Res Commun; 2000 Apr; 271(1):268-74. PubMed ID: 10777713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of IgA nephropathy.
    Feehally J; Allen AC
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role.
    Hiki Y; Horii A; Iwase H; Tanaka A; Toda Y; Hotta K; Kobayashi Y
    Contrib Nephrol; 1995; 111():73-84. PubMed ID: 7758349
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A; Monteiro R; Coppo R
    G Ital Nefrol; 2006; 23(3):313-22. PubMed ID: 16868911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
    Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD.
    Rudd PM; Fortune F; Patel T; Parekh RB; Dwek RA; Lehner T
    Immunology; 1994 Sep; 83(1):99-106. PubMed ID: 7821975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
    He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
    Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB; Cooper HJ; Tomana M; Kulhavy R; Hiki Y; Toma K; Emmett MR; Mestecky J; Marshall AG; Novak J
    J Biol Chem; 2005 May; 280(19):19136-45. PubMed ID: 15728186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
    Inoue T; Sugiyama H; Hiki Y; Takiue K; Morinaga H; Kitagawa M; Maeshima Y; Fukushima K; Nishizaki K; Akagi H; Narimatsu Y; Narimatsu H; Makino H
    Clin Immunol; 2010 Sep; 136(3):447-55. PubMed ID: 20538527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoglobulin A and renal diseases].
    Matousovic K; Mestecky J; Tomana M; Novak J
    Vnitr Lek; 2006 Mar; 52(3):256-62. PubMed ID: 16722157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1--implications in IgA-mediated disease.
    Almogren A; Kerr MA
    Mol Immunol; 2008 Jan; 45(1):87-94. PubMed ID: 17606293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I; Gejyo F
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.
    Allen AC; Harper SJ; Feehally J
    Clin Exp Immunol; 1995 Jun; 100(3):470-4. PubMed ID: 7774058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
    Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
    J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
    Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant glycosylation of IgA from patients with IgA nephropathy.
    Baharaki D; Dueymes M; Perrichot R; Basset C; Le Corre R; Clèdes J; Youinou P
    Glycoconj J; 1996 Aug; 13(4):505-11. PubMed ID: 8872105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation].
    Matousovic K; Konecný K; Mĕstecký J; Tomana M; Novák J
    Cas Lek Cesk; 2002 Nov; 141(23):729-34. PubMed ID: 12650029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.